switching from compounded tirzepatide to zepbound (Tirzepatide): A Q&A on the Mounjaro-Like Weight Loss Drug Eli Lilly is now offering

Because microdosing starts at a very low level, its designed to reduce the chance of more disruptive side effects that can occur at higher doses

Skipping weeks can reduce appetite suppression, increase cravings, and slow metabolism restorationpotentially reversing the progress you've made

Check your tirzepatide dosing in units carefully to ensure accuracy at this level

Key highlights Tirzepatide (also known by FDA-approved brand names Mounjaro and Zepbound) is a dual receptor agonist (GLP-1/GIP) that helps reduce appetite, control blood sugar, and promote greater weight loss than single receptor GLP-1 receptor agonists, such as semaglutide

Tirzepatides additional GIP receptor activity makes it distinct from Trulicity and may contribute to its enhanced effects on weight loss and metabolic health

Compounded semaglutide can be safe